Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123186) titled 'Clinical study of Tamsulosin on the recovery of voluntary urinary function after total mesorectal excision(TME) for rectal cancer' on April 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Sixth Affiliated hospital of Sun Yat-sen University
Condition:
Rectal cancer
Intervention:
Tamsulosin Group:For patients scheduled to undergo TME surgery, tamsulosin 0.4 mg once daily is administered 4 hours before surgery until the second day after surgery. The catheter is removed on the second day after surgery.
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 202...